Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 2011 AL 2025

CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression

Coughlin DG, Jain L, Khrestian M, Bozoki AC, Galvin JE, Irwin DJ, Lippa CF, Litvan I, Pillai JA, Tousi B, Lopez OL, Berman S, Tsuang DW, Zabetian CP, Fleisher JE, Taylor AS, Leverenz JB, Bekris LM, Galasko D; Dementia With Lewy Bodies Consortium.

Neurology. 2025 Dec 23;105(12):e214346. doi: 10.1212/WNL.0000000000214346. Epub 2025 Nov 17.

GLP-1 receptor agonists in Alzheimer's and Parkinson's disease: endocrine pathways, clinical evidence, and future directions

Gandhi A, Parhizgar A.

Front Endocrinol (Lausanne). 2025 Nov 20;16:1708565. doi: 10.3389/fendo.2025.1708565. eCollection 2025.

Microbiota-brain interaction: The role of gut-derived proteins in addressing various neurological disorders including Parkinson's (PD) and Alzheimer's diseases (AD)

Taj T, Kaushik M, Islam A, Das J, Kumar B, Hussain MS, Ramzan M, Ashique S, Tariq M, Sridhar SB, Yasmin S, Panigrahy UP, Malik T, Ansari MY.

Biomed Pharmacother. 2025 Dec;193:118861. doi: 10.1016/j.biopha.2025.118861. Epub 2025 Dec 8.

Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024

Isaković J, Athanassiadis A, Khubeis M.

J Mol Med (Berl). 2025 Dec 13;104(1):2. doi: 10.1007/s00109-025-02613-1.

The impact of intermittent fasting on cognitive function and neuroprotection: A literature review

Polak A, Kosiń K, Liszka W, Malina M, Kiwior J.

Wiad Lek. 2025;78(10):2167-2172. doi: 10.36740/WLek/210261.

BACE1: Biological Functions and Involvement in the Pathophysiology of Alzheimer's Disease and Other Neurological Disorders

Bartolić M, Bosak A.

Biofactors. 2025 Nov-Dec;51(6):e70071. doi: 10.1002/biof.70071.

[Neurogenesis in neurodegeneration: multifactorial regulation, mechanisms of impairment, and therapeutic strategies]

Yusupov FA, Abdykadyrov MS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(12):14-21. doi: 10.17116/jnevro202512512114.

[Diagnosis of Alzheimer's disease using biological markers in corticobasal syndrome]

Grishina DA, Grinyuk VV, Nodel MR, Tyurina AY, Mkhitaryan EA, Chervyakova YI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(8):133-139. doi: 10.17116/jnevro2025125081133.

Doxycycline: An essential tool for Alzheimer's disease

Forloni G.

Biomed Pharmacother. 2025 Jul;188:118159. doi: 10.1016/j.biopha.2025.118159. Epub 2025 May 13.

Grueneberg Ganglion: An Unexplored Site for Intranasal Drug Delivery in Alzheimer's Disease

Kakoty V, Kang JH, Lee OH, Oh DH, Ko YT.

ACS Chem Neurosci. 2025 Sep 17;16(18):3425-3437. doi: 10.1021/acschemneuro.5c00376. Epub 2025 Sep 4.

Interferon Regulatory Factors as a Potential Therapeutic Target for Neuroinflammation: A Focus on Alzheimer's Disease

Fan X, Diao W, Wang H, Yin X, Qian W.

Int J Mol Sci. 2025 Mar 23;26(7):2906. doi: 10.3390/ijms26072906.

Anti-neurodegenerative treatment in Alzheimer's disease: Multifaceted mechanisms of action of berberine

Song D, Zhang C.

Int J Clin Pharmacol Ther. 2025 Sep;63(9):432-438. doi: 10.5414/CP204725.

Beyond Alzheimer's disease-translating biomarker insights across CNS diseases

Brady LS, Mahinrad S, Edelmayer RM, Potter WZ, Hutten SJ, Anticevic A, Taylor-Burds C, Winston CN, Coetzee T, Paulsen JS, Mantua V, Childers EP, Kolb HC, Jack CR Jr, Jagust WJ, Wagner JA, Sivakumaran S, Shaw L, Sharma VM.

Sci Transl Med. 2025 Nov 5;17(823):eadr2511. doi: 10.1126/scitranslmed.adr2511. Epub 2025 Nov 5.

ITPR1 autoantibody-associated autoimmunity as a cause of newly emerging cognitive decline mimicking Alzheimer's disease: Case report and brief review of the literature

Kunath N, Ramfjord HAB, Kvisvik EV, Konyves-Kolonics M, Rolfseng Grøntvedt G, Serysheva II, Komorowski L, Wildemann B, Jarius S.

J Neuroimmunol. 2025 Dec 15;409:578774. doi: 10.1016/j.jneuroim.2025.578774. Epub 2025 Oct 9.

Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case Report

Rodríguez-Baz Í, Benejam B, Morcillo-Nieto AO, Vaqué-Alcázar L, Arriola-Infante JE, Camacho V, Aranha MR, Carmona-Iragui M, Videla L, Barroeta I, Fernández S, Zsadanyi SE, Giménez S, Arranz J, Maure Blesa L, Alcolea D, Lleó A, Bejanin A, Fortea J.

Neurology. 2025 Jan 14;104(1):e210179. doi: 10.1212/WNL.0000000000210179. Epub 2024 Dec 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias